These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12903136)

  • 1. Down regulation of human immunodeficiency virus type-1 (HIV-1) expression by Vif antisense RNA expression vectors in transfected cells.
    Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Kobayashi H; Ishikawa K; Osei-Kwasi M; Ampofo WK; Ofori-Adjei D; Inagaki Y; Yamamoto N; Takaku H
    Nucleic Acids Res Suppl; 2002; (2):123-4. PubMed ID: 12903136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets.
    Barnor JS; Miyano-Kurosaki N; Takaku H; Yamaguchi K; Sakamoto A; Ishikawa K; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1745-61. PubMed ID: 16438045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.
    Veres G; Junker U; Baker J; Barske C; Kalfoglou C; Ilves H; Escaich S; Kaneshima H; Böhnlein E
    J Virol; 1998 Mar; 72(3):1894-901. PubMed ID: 9499041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.
    Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Sakamoto A; Ishikawa K; Inagaki Y; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D; Takaku H
    Biochem Biophys Res Commun; 2004 Jul; 320(2):544-50. PubMed ID: 15219863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral-mediated delivery of combined HIV-1 decoy TAR and Vif siRNA as a single RNA molecule that cleaves to inhibit HIV-1 in transduced cells.
    Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Abumi Y; Ishikawa K; Yamamoto N
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):431-4. PubMed ID: 16247965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Arrigo SJ; Chen IS
    Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
    Chadwick DR; Lever AM
    Gene Ther; 2000 Aug; 7(16):1362-8. PubMed ID: 10981662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.
    Kao S; Miyagi E; Khan MA; Takeuchi H; Opi S; Goila-Gaur R; Strebel K
    Retrovirology; 2004 Sep; 1():27. PubMed ID: 15373943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products.
    Ludwig LB; Ambrus JL; Krawczyk KA; Sharma S; Brooks S; Hsiao CB; Schwartz SA
    Retrovirology; 2006 Nov; 3():80. PubMed ID: 17090330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure.
    Henzler T; Harmache A; Herrmann H; Spring H; Suzan M; Audoly G; Panek T; Bosch V
    J Gen Virol; 2001 Mar; 82(Pt 3):561-573. PubMed ID: 11172097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique characteristics of HIV-1 Vif expression.
    Wang H; Sakurai A; Khamsri B; Uchiyama T; Gu H; Adachi A; Fujita M
    Microbes Infect; 2005 Mar; 7(3):385-90. PubMed ID: 15784183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
    Schwartz S; Felber BK; Pavlakis GN
    Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of human immunodeficiency virus type 1 vif gene.
    Sakai K; Horiuchi M; Iida S; Fukumori T; Akari H; Adachi A
    Virus Genes; 1999; 18(2):179-81. PubMed ID: 10403705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect.
    Xing HC; Xu XY; Liu Z; Wang QH; Yu M; Si CW
    Jpn J Infect Dis; 2004 Jun; 57(3):91-6. PubMed ID: 15218216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1.
    Ochsenbauer C; Bosch V; Oelze I; Wieland U
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1389-95. PubMed ID: 8757978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
    Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
    J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.